Silantes GmbH

Gollierstraße 70c
80339 Munich, Germany

Phone: +49 (0)89 500 941-0
Fax: +49 (0)89 500 941-29

Silantes uses a new technology to produce biomolecules such as amino acids, nucleotides, peptides, proteins and DNA. The company has a staff of highly skilled scientists from the fields of molecular biology, microbiology, biochemistry and biotechnology who can provide flexible, intelligent and customer-oriented responses to the needs of science and industry.
Silantes was founded in 1998 by a researcher from the German Max-Planck-Institute, who developed a new method for the production of stable isotope labeled biomolecules based on chemolithoautotrophic bacteria (patent pending). This technology exploits the fact that chemolithoautotrophic bacteria can metabolise inorganic carbon in a pathway similar to that of green plants. Chemolithoautotrophic bacteria combine the advantage of green plants of being able to assimilate CO2 with the advantages of bacteria of being more productive and reliable as well as capable of expressing heterologous proteins.

Latest News of our Members

  • Insilico and Teva enter collaboration to apply predictive Digital Twins for biopharmaceutical production

    Insilico Biotechnology AG21.02.2019More
  • Gold für Symrise: Nachhaltigkeitsmanagement ausgezeichnet

    Symrise AG 4.02.2019More
  • Bayer Partners with Genedata to Digitalize Crop Science Research and Development

    Genedata GmbH27.09.2018More
  • All links

Membership Application

Do you want to become a member of the IWBio?

Download the membership application form here. (PDF in German version)

You can find our statute here. (PDF in German version)

In cases of questions or suggestions, please contact us here: +49 (0)30-374415-850